Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
BioProtect
Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in up to 20 males who underwent radiotherapy treatment for prostate cancer. Study utilized pre and post gel insertion CT images to determine endpoints.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Males
At least 18 years of age
Undergone external beam or brachy radiation therapy with a hydrogel spacer in place
You may not be if
Clinical and pathological data are not available
Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension
